I'll research Palantir's recent financials, guidance, and market context before writing the preview.Good, I now have sufficient material. Let me do a couple quick calculations (valuation multiples, price move context) before writing.Now I have all the pieces I need. Let me write the earnings preview.# Palantir Technologies (PLTR) — Q2 2026 Earnings Preview Reports: Monday, August 3, 2026, after market close | Call: 5:00 PM ET
Palantir heads into Monday's print off the back of one of the strongest quarters in its history — and one of the roughest stretches for the stock since going public. After three consecutive years of massive gains, Palantir stock has fallen 27% in 2026 amid broad fears that artificial intelligence could disrupt software, and shares are down 37% from their record closing high of $207.18 set on Nov. 3, 2025. June was brutal in particular — the stock suffered a seven-day losing streak spanning June 16 through June 25 in which shares broke below multiple key levels of technical support, and by June 25 shares had touched a new 12-month low of $107.53, down 31% for the month and 39% for the year, roughly 48% off the November 2025 record high. Shares have since partially recovered (closing around $123 heading into the print) on a Nvidia partnership announcement and a couple of analyst upgrades, but remain well below the highs — leaving a wide dispersion of views on what's priced in.
Consensus expects another blowout quarter, though a slight deceleration from Q1's record growth rate: the Street is expecting sales growth of 80% to $1.8 billion, operating margins of approximately 60% (up more than 1,500 basis points year-over-year), and EPS growth of 117% to $0.35. Company guidance is roughly in line: Q2 revenue of $1.797–$1.801 billion and adjusted operating income of $1.063–$1.067 billion, per Palantir's own outlook issued alongside Q1 results.
Sentiment into the print is split but skews bullish among sell-side names covering the stock: Oppenheimer analysts are bullish on the expected results, anticipating an 85% year-over-year revenue beat and an outlook raise, even as shares tumbled as much as 10.4% in the days leading into earnings, marking the stock's worst day in over five months. More broadly, the stock carries an average "Overweight" rating with a $189.87 price target — implying meaningful upside — with 17 of 33 firms rating it Buy, three Overweight, 11 Hold and two Sell (as of late June).
Q1 2026 was, by the company's own description, a record-setter. Highlights:
The bull case going into Q2 is essentially: can this acceleration continue for an 11th–12th consecutive quarter, and does the FY26 guide get raised again? Management flagged that its "biggest problem" is capacity/demand rather than sales effort, and specific customer references (AIG's agentic underwriting build, GE Aerospace, ShipOS with the Navy, a $300M USDA award, Maven usage "4x over the past 12 months") were used to reinforce durability.
1. Government/political overhang. Shares wobbled in early July after a Financial Times report raised concerns about the company's political standing and how Democratic lawmakers could potentially target Palantir, imperiling its business with the U.S. government — Palantir pushed back publicly, noting it has worked with the U.S. government and its allies across five administrations. Watch for management commentary on the durability of bipartisan government demand, appropriations/continuing-resolution risk (flagged on the Q1 call by CTO Shyam Sankar as a perennial, largely un-controllable variable), and Maven/TITAN program funding.
2. International/sovereignty pushback. Europe is showing signs of "AI sovereignty" friction: France's domestic intelligence agency, DGSI, is replacing Palantir's data tools with a local alternative from Chapsvision as part of a French push to promote sovereign technology, with civil servants to get access to a Mistral-powered AI assistant instead. The UK's NHS data contract has also faced review pressure. International commercial/government revenue is a small slice of the mix (Q1 international commercial was $179M, +26% y/y) but the optics matter for the "critical Western infrastructure" narrative Karp leans on.
3. Competitive/AI-disruption narrative. The stock's 2026 drawdown has been driven less by fundamentals and more by fears that cheaper frontier models and AI-native competitors could commoditize the software layer Palantir sits on. Management's counter (reiterated repeatedly on the Q1 call) is the "Ontology"/AIP governance layer and Jevons-paradox argument that cheaper tokens increase, not decrease, demand for Palantir's orchestration layer. The June/July Nvidia partnership to build custom government AI models was explicitly framed as reinforcing this moat, and helped snap the June losing streak — investors pushed shares higher after the company announced a new strategic initiative with Nvidia to build custom AI models for the U.S. government, though the stock has since given back some of that bounce.
4. Valuation remains the central bear argument. Even after the pullback, PLTR trades at roughly 38–41x the FY26 consensus revenue guide (~$7.66B) and a market cap near $295–316B at a ~$123 share price — among the richest multiples in software/AI infrastructure. Any miss, deceleration in U.S. commercial growth, or softer-than-expected guidance raise is likely to be punished given how much perfection is still priced in, while a beat-and-raise repeat of Q1 could reignite the bull case quickly given how far shares have fallen from the November 2025 high.
5. Diversification proof points. Palantir has been pushing to broaden its commercial base beyond the Pentagon and top government accounts — e.g., its first Mexican commercial client win with insurer GNP Seguros — a data point bulls will want to see repeated in new logos/expansion this quarter.
Palantir goes into Monday's print as a "battleground stock": bulls are focused on the company's extremely robust top and bottom-line growth trajectory and its role as a critical provider of AI technology, while bears worry about an elevated valuation and intensifying competition. The fundamental story — accelerating U.S. growth, expanding margins, a Rule of 40 score matched by few other companies — remains intact based on Q1's results and guidance. The stock's 2026 underperformance has been more about multiple compression amid AI-disruption fears and political/international noise than about any crack in the underlying numbers. A clean beat-and-raise, particularly on U.S. commercial growth and full-year guidance, would likely be read as validation that the sell-off was overdone; anything short of that — especially commentary suggesting government funding friction or European contract erosion is spreading — risks reigniting the valuation debate that has weighed on shares since June.